Protide Health

Listings clearly state products are for laboratory research use only.

No therapeutic, dosing, or human-use claims anywhere in the listing.

Batch-tied COAs (HPLC purity + mass-spec identity) exist and are accessible.

Vial sizes and prices are listed clearly and consistently, no bait pricing.

A stated shipping, tracking, and reship/refund policy is published.

No unresolved counterfeit, non-delivery, or COA-forgery reports on file. 2026-08-29: ALL SIX HOLD AT PASS and the recount confirms the archive byte-identical to yesterday. The COA archive paginates '1 2 3 4 ... 16' and states verbatim 'Across 152 public third-party COAs from the last 180 days, our peptides average 99.71% purity.' The exemplar certificate is unchanged: 'NAD+ 500mg COA #2608120535 / COA: 2608120535 / Lot: PH-na500-0509 / Reported Date: 08/17/2026 / 99.97%.' THE DUAL-NUMBER PATTERN PERSISTS AND AGAIN READS AS PERIODIC RETESTING OF A RETAINED LOT, NOT A DISCREPANCY: Lot PH-bt60-0316 appears at COA 2608100315 (99.62%, 08/13/2026) and COA 2608120530 (99.10%, 08/17/2026) - same lot, sequential dates, purity drifting down slightly as one would expect on retest. RECOMMEND A VENDOR QUERY ASKING PROTIDE TO ANNOTATE RETESTS, which would convert this from an ambiguity into a strength. Anti-impersonation banner verbatim intact: 'Our only official store is protidehealth.com. We are not on Telegram, WhatsApp, or any other platform.' Returns restrictive but fully disclosed. NOTE AGAINST OUR OWN RECORD: this file's historical COA count of 20 is now more than SEVEN TIMES behind the live archive of 152 - the recorded figure, not the vendor, is what is stale. || PRIOR: 2026-08-28: ALL SIX HOLD AT PASS; still the cleanest file in the directory, and the COA archive has grown far beyond what this file recorded. The archive now paginates '1 2 3 4 ... 16' and states verbatim 'Across 152 public third-party COAs from the last 180 days, our peptides average 99.71% purity' - this file previously recorded 20 certificates and was well behind. Page-one certificates are all Aug 2026, 99.10%-99.97%, each with COA number, lot, reported date and a downloadable PDF (e.g. NAD+ 500mg COA #2608120535 / Lot PH-na500-0509 / Reported 08/17/2026 / 99.97%). THE DUAL-COA-NUMBER PATTERN PERSISTS AND AGAIN READS FAVOURABLY as periodic retesting of a retained lot rather than a discrepancy: PH-bt60-0316 appears at COA 2608100315 (99.62%, reported 08/13) and COA 2608120530 (99.10%, reported 08/17) - same lot, sequential dates. Protide publishes no retest annotation to say so; RECOMMEND A VENDOR QUERY ASKING THEM TO LABEL RETESTS, which would convert an ambiguity into a strength. Anti-impersonation banner verbatim intact: 'Our only official store is protidehealth.com. We are not on Telegram, WhatsApp, or any other platform.' Returns are restrictive but FULLY DISCLOSED - 'all sales are final', 7-day claim window, exceptions for wrong product shipped and damaged/defective only - with no risk-of-loss ambiguity. || PRIOR: 2026-08-27: STILL THE CLEANEST FILE IN THE DIRECTORY, and one previously-logged possible defect now resolves in the vendor's favour. All six hold on first-hand read. The anti-impersonation banner is verbatim intact sitewide: 'Our only official store is protidehealth.com. We are not on Telegram, WhatsApp, or any other platform.' THE COA ARCHIVE HAS GROWN FROM 12 TO 20 CERTIFICATES, spanning 99.10%-99.97%, each with a COA number, lot, reported date and downloadable PDF, all dated Jul-Aug 2026, each linking HPLC-UV chromatogram, mass identification and endotoxin replicates. THE DUAL-COA-NUMBER ITEM IS REINTERPRETED FAVOURABLY. It was logged on 2026-08-26 as a possible discrepancy on one lot; it now appears on FOUR lots with reported dates in sequence - PH-bt60-0316 (#2608120530 at 99.10% reported 08/17, #2608100315 at 99.62% reported 08/13), PH-te10-0616 (99.93%/99.55%), PH-mc20-0605 (99.53%/99.85%), PH-ko80-0616 (99.73%/99.77%). A single lot under two numbers reads as an error; four lots under paired numbers with sequential dates reads as PERIODIC RETESTING OF A RETAINED LOT, which is good practice. Protide publishes no retest annotation to say so. RECOMMENDATION: ask the vendor to label retests explicitly - that one change would turn this from an ambiguity into a directory-leading strength. Return policy is restrictive but FULLY DISCLOSED and correctly framed ('all sales are final', 7-day claim window, wrong/damaged-product exceptions only) with no risk-of-loss ambiguity; reship_policy holds at pass because the check asks for a stated policy, not a generous one. Minor, unchanged, not scored: three entries carry bare 4-digit lots outside the PH- scheme; a login modal advertises '50+ research peptides' while ~10 SKUs are publicly priced - not a transparency failure for what is shown. || PRIOR: 2026-08-26: ALL SIX HOLD AT PASS on first-hand read; still the cleanest file in the directory. Anti-impersonation banner confirmed verbatim in server-side HTML: 'Our only official store is protidehealth.com. We are not on Telegram, WhatsApp, or any other platform.' COA archive still lists exactly 12 certificates, purity 99.10%-99.97%, with both previously cited lots present - NAD+ 500mg COA #2608120535 / Lot PH-na500-0509 at 99.97%, and BPC-157/TB-500 30/30mg COA #2608120530 / Lot PH-bt60-0316 at 99.10% - each linking a PDF containing 'the HPLC-UV chromatogram, mass identification, endotoxin replicates.' Footer bars dosing language explicitly: 'Nothing on this site should be construed as medical advice, dosing, or administration guidance.' No consult funnel anywhere on the site. TWO MINOR INCONSISTENCIES, RECORDED NOT SCORED: lot PH-bt60-0316 appears under TWO different COA numbers with two different purities (2608120530 at 99.10% and 2608100315 at 99.62%) - benign if they are two assays of one lot, but worth asking the vendor to reconcile since the lot is the controlling identifier; and three archive entries carry bare 4-digit lots (0625, 1021, 0603) outside the PH- scheme. Also not scored: a login modal advertises 'our full catalog of 50+ research peptides and third-party COAs' while only ~10 SKUs are publicly priced - not a transparency failure for what IS shown, but the gap between 50+ and 10 is worth watching if the public surface shrinks further. No adverse reports found; the only search returns were automated trust-score pages (Scam-Detector 53.4), which are algorithmic heuristics with no incident detail and were deliberately not scored. || PRIOR: 2026-08-25: ALL SIX HOLD AT PASS. /coa-archive/ read first-hand and it remains THE CLEANEST COA ARCHIVE IN THE DIRECTORY, which is worth stating precisely rather than in the abstract: 12 certificates, each with a DISTINCT COA number and lot ID (PH-na500-0509, PH-bt60-0316, ...), per-lot purity 99.10-99.97%, reported dates 08/13-08/17/2026, each with both a viewable page AND a downloadable PDF, and each described as carrying an HPLC-UV chromatogram, mass identification AND endotoxin replicates. That is the full HPLC + MS pairing the check asks for, plus more. No new COAs in the last eight days - normal cadence for a 12-SKU catalog, explicitly NOT a lapse and not scored as one. Two RUO notices above the fold, a full 503A/503B + FDA disclaimer, and an anti-impersonation banner reading 'Our only store is protidehealth.com. We are not on Telegram, WhatsApp, or other platforms' - that last item is proactive scam hygiene and is credited here. Shipping and returns stated concretely (2-3 day US, free over $199, orders after 12 PM PST ship next day, Shipping & Returns page linked). NO CLINICIAN OR CONSULT FUNNEL ANYWHERE, which is the direct contrast to today's Kaia escalation and to the standing PSPeptides finding - Protide sells to researchers and stops there. No health claims observed. No adverse public reports surfaced. || PRIOR: 2026-08-24: ALL SIX HOLD AT PASS first-hand. /coa-library/ up with batch lookup; /coa-archive/ shows FRESH COAs reported 08/16-08/17/2026 (NAD+ 500mg #2608120535, BPC-157/TB-500 #2608120530, Tesamorelin/Ipamorelin #2608120525) each with HPLC-UV chromatogram, mass ID, endotoxin replicates, downloadable PDFs. RUO banner site-wide; 503A/503B disclaimer; anti-impersonation notice ('not on Telegram/WhatsApp'); shipping/returns linked. Nothing adverse. || PRIOR: 2026-08-23: ALL SIX HOLD AT PASS on first-hand read: RUO banner, anti-impersonation notice ('We are not on Telegram, WhatsApp, or other platforms'), public /coa-library/ with LC-MS identity + HPLC-UV purity + endotoxin per batch, clear vial pricing, /return-policy/ linked, footer explicitly disclaims 503A/503B status and dosing guidance. No adverse reports. Nothing changed vs 2026-08-20. || PRIOR: 2026-08-20: OPEN ITEM CLOSED FIRST-HAND, AND IT CLOSED IN PROTIDE'S FAVOUR - WHICH IS THE POINT OF HAVING CHECKED. Yesterday recorded a SECONDARY third-party profile describing Protide as 'ISO-certified, GMP-compliant' and flagged it as an imprecise formulation of exactly the issue under examination at Koi Peptides, to be verified on Protide's own pages BEFORE the COA standard is published so the standard is applied evenly rather than to whichever vendor was read most closely. /about/ (updated 2026-08-19) HAS NOW BEEN READ IN FULL. PROTIDE'S OWN COPY, VERBATIM: 'ISO-Certified Synthesis: We partner with ISO-certified and GMP-compliant facilities'; 'Manufactured in ISO 9001:2015 CERTIFIED, GMP compliant facilities'; 'Every batch is independently tested by FREEDOM DIAGNOSTICS, a third-party U.S. laboratory ... identity by LC-MS, purity by HPLC-UV, endotoxin by LAL assay (USP <85>), and net content.' THREE THINGS MAKE THIS THE CORRECT FORMULATION, AND THEY ARE THE THREE THINGS KOI'S MARKETING GETS WRONG: (1) THE STANDARD IS NAMED - ISO 9001:2015, not a bare 'ISO-certified'. (2) IT IS APPLIED TO THE RIGHT ENTITY - the SYNTHESIS FACILITY, not the testing laboratory. (3) THE TESTING LAB IS NAMED WITH NO ACCREDITATION CLAIM ATTACHED - Freedom Diagnostics appears by name, with its methods listed, and NO ISO/IEC 17025 ASSERTION ANYWHERE. The bare phrase 'ISO-certified' in the bullet heading is loose standing alone, but it is defined two paragraphs later as 9001:2015 and never migrates onto the lab. FAVOURABLE FINDING, ITEM CLOSED. IT ALSO SUPPLIES THE CONTROL CASE THE KOI FINDING NEEDED: THE SAME LABORATORY, DESCRIBED CORRECTLY BY ONE VENDOR AND INCORRECTLY BY ANOTHER. That is the cleanest available evidence that the Koi problem is marketing copy and not the laboratory - and it means the COA standard can be published without the even-handedness objection. ALSO FAVOURABLE AND NEW: Protide runs an anti-impersonation banner on every page - 'Our only store is protidehealth.com. We are not on Telegram, WhatsApp, or other platforms.' Search this run surfaced protidehealthpeptide.com as a SEPARATE DOMAIN. ADDED TO THE DISAMBIGUATION REGISTER: protidehealthpeptide.com IS NOT protidehealth.com. Not assessed, not attributed, and NO CLAIM IS MADE ABOUT IT HERE. STAND [...earlier history truncated - see compliance-reports/ for the full record...]